163 related articles for article (PubMed ID: 11163768)
1. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.
Gao B; Shen X; Kunos G; Meng Q; Goldberg ID; Rosen EM; Fan S
FEBS Lett; 2001 Jan; 488(3):179-84. PubMed ID: 11163768
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
[TBL] [Abstract][Full Text] [Related]
3. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
5. Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines.
Barton BE; Murphy TF; Shu P; Huang HF; Meyenhofer M; Barton A
Mol Cancer Ther; 2004 Oct; 3(10):1183-91. PubMed ID: 15486184
[TBL] [Abstract][Full Text] [Related]
6. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
7. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
8. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
10. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
11. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
12. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.
Guschin D; Rogers N; Briscoe J; Witthuhn B; Watling D; Horn F; Pellegrini S; Yasukawa K; Heinrich P; Stark GR
EMBO J; 1995 Apr; 14(7):1421-9. PubMed ID: 7537214
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones.
Krasil'nikov M; Shatskaya V
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):369-76. PubMed ID: 12589944
[TBL] [Abstract][Full Text] [Related]
14. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
15. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
[TBL] [Abstract][Full Text] [Related]
16. Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes.
Chen J; Kunos G; Gao B
FEBS Lett; 1999 Aug; 457(1):162-8. PubMed ID: 10486586
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
[TBL] [Abstract][Full Text] [Related]
18. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
19. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
20. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
